US Foods Holding Corp. (USFD)

Reports for US Foods Holding Corp.

US Foods Holding Corp.
USFD
11-05-2025
Read Report
US Foods Holding Corp.
USFD
14-03-2025
Read Report

Industries

Healthcare
104
View Industry
Food
104006
View Industry

Analysis

No analyses available for US Foods Holding Corp. yet.

Latest News about US Foods Holding Corp.

NASDAQ
Citigroup Initiates Coverage of US Foods Holding (BMV:USFD) with Buy Recommendation
1748069138 | NASDAQ
NASDAQ
IJJ, EXE, USFD, COHR: ETF Inflow Alert
1734717412 | NASDAQ
NASDAQ
USFD Factor-Based Stock Analysis - Martin Zweig
1734555600 | NASDAQ
NASDAQ
US Foods (USFD) Surpasses Q3 Earnings and Revenue Estimates
1730984405 | NASDAQ
BIZSTNDRD
USFDA approves Pfizer's Hympavzi for rare bleeding disorder hemophilia
1728670375 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences gets USFDA nod for generic schizophrenia treatment drug
1728557724 | BIZSTNDRD
BIZSTNDRD
Lupin share down 3% as USFDA issues 5 observations for Biotech unit in Pune
1728280794 | BIZSTNDRD
BIZSTNDRD
Indoco Remedies shares rise over 3% on USFDA nod for allergy drug
1728029158 | BIZSTNDRD
BIZSTNDRD
Shivalik Rasayan stock skyrockets over 14% on USFDA nod for API facility
1727943137 | BIZSTNDRD
BIZSTNDRD
Alembic Pharma share price gains 5% after USFDA okays seizures drug
1727938223 | BIZSTNDRD
BIZSTNDRD
Eli Lilly's blockbuster weight-loss drug no longer in shortage in US: USFDA
1727924311 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences receives USFDA approval to produce prostrate cancer drug
1727868946 | BIZSTNDRD
BIZSTNDRD
Aurobindo Pharma subsidiary gets 10 observations from USFDA for API plant
1727697659 | BIZSTNDRD
BIZSTNDRD
Aurobindo Pharma share down 4% as arm gets 10 observations from USFDA
1727687010 | BIZSTNDRD
BIZSTNDRD
Lupin share falls over 2% as USFDA issues 3 observations for Pithampur unit
1727673082 | BIZSTNDRD
BIZSTNDRD
Zydus gets USFDA approval to produce its generic prostate cancer drug
1727528782 | BIZSTNDRD
BIZSTNDRD
Aurobindo Pharma arm receives EIR from USFDA for Andhra Unit; stock down 2%
1726651421 | BIZSTNDRD
BIZSTNDRD
Strides Pharma Science gets USFDA nod for generic antidepressant tablets
1726493078 | BIZSTNDRD
BIZSTNDRD
USFDA cites manufacturing lapses at Zydus Lifesciences' Gujarat plant
1726381700 | BIZSTNDRD
BIZSTNDRD
USFDA approves injectable version of Roche's multiple sclerosis therapy
1726198591 | BIZSTNDRD
BIZSTNDRD
USFDA issues six observations for Granules' Gagillapur unit; stock falls 5%
1725860372 | BIZSTNDRD
BIZSTNDRD
Suven Pharma hits record high on USFDA's 'VAI' tag to Hyderabad facility
1725855513 | BIZSTNDRD
BIZSTNDRD
Dr Reddy's gets USFDA's inspection report for Srikakulam-based API plant
1725623581 | BIZSTNDRD
BIZSTNDRD
Strides Pharma hits all time high after USFDA approval for this drug
1725610531 | BIZSTNDRD
BIZSTNDRD
USFDA still struggling to conduct pending drug inspections after Covid
1725546470 | BIZSTNDRD
BIZSTNDRD
Alembic Pharma shares jump 5% after USFDA approval; check details here
1725526100 | BIZSTNDRD
BIZSTNDRD
Dr Reddy's, Lupin recall products in US due to manufacturing issues: USFDA
1725458804 | BIZSTNDRD
BIZSTNDRD
Biocon subsidiary gets USFDA nod for generic drug for chronic heart failure
1725210310 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences gets USFDA nod to mkt Scopolamine transdermal system
1725017442 | BIZSTNDRD
BIZSTNDRD
Torrent Pharma rallies 4% as USFDA issues EIR for Gujarat facility
1725001640 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences share price zooms 4% on USFDA nod for Parkinson's drug
1724819482 | BIZSTNDRD
BIZSTNDRD
USFDA approval sends this multibagger pharma stock to 52-week high
1724751103 | BIZSTNDRD
BIZSTNDRD
Alembic Pharma shares rise after USFDA drug approval; check details here
1724735611 | BIZSTNDRD
BIZSTNDRD
Aurobindo, others recall products in US market over production issue: USFDA
1724682472 | BIZSTNDRD
BIZSTNDRD
USFDA pulls up Eugia for manufacturing lapses at its Telangana plant
1724574632 | BIZSTNDRD
BIZSTNDRD
Wanbury jumps 4% after firm gets zero form 483 observations from USFDA
1724388691 | BIZSTNDRD
BIZSTNDRD
Indoco Remedies stock soars over 5% on USFDA approval for opioids drug
1724227778 | BIZSTNDRD
BIZSTNDRD
Marksans Pharma hits 52-week high after USFDA issues EIR for Goa facility
1724144608 | BIZSTNDRD
BIZSTNDRD
Strides Pharma falls over 4% after USFDA gives VAI tag to Chennai facility
1724059858 | BIZSTNDRD
BIZSTNDRD
Aurobindo Pharma arm gets warning letter from USFDA for Telangana unit
1723792094 | BIZSTNDRD
BIZSTNDRD
Aurobindo Pharma stock tanks 6% after unit gets warning letter from USFDA
1723786920 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences hits all time high on USFDA nod for drug worth $2 Bn
1723188619 | BIZSTNDRD
BIZSTNDRD
USFDA issues 3 observations to Gland Pharma Hyderabad Unit, stock down 6%
1722837115 | BIZSTNDRD
BIZSTNDRD
USFDA scrutiny delays generic drug approvals for major Indian pharma firms
1722317800 | BIZSTNDRD
BIZSTNDRD
Sun Pharma shares hit 52-week high on USFDA approval for alopecia drug
1721976473 | BIZSTNDRD
BIZSTNDRD
Zydus Life stock price jumps 6% on USFDA nod for Valsartan tablets
1721811838 | BIZSTNDRD
BIZSTNDRD
Gland Pharma, Zydus Lifesciences secure USFDA approvals for key medications
1721732569 | BIZSTNDRD
BIZSTNDRD
Zydus Life Vadodara facility gets OAI report from USFDA, stock falls 3%
1721367077 | BIZSTNDRD
BIZSTNDRD
Glenmark Pharma receives USFDA approval for seizure treatment drug
1721217284 | BIZSTNDRD
BIZSTNDRD
Zydus Lifesciences hits all time high on USFDA nod for multiple drugs
1720675432 | BIZSTNDRD
BIZSTNDRD
Zydus Life gets USFDA approval to market heart failure treatment drug
1720611753 | BIZSTNDRD
BIZSTNDRD
Alembic Pharma receives USFDA nod for Bromfenac Ophthalmic Solution
1720528559 | BIZSTNDRD
BIZSTNDRD
Dr Reddy's, Sun Pharma recall drugs in US due to production issues: USFDA
1720096682 | BIZSTNDRD
BIZSTNDRD
USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility
1720055922 | BIZSTNDRD
BIZSTNDRD
USFDA approves second Alzheimer's drug that can modestly slow disease
1719969549 | BIZSTNDRD
BIZSTNDRD
Jubilant Ingrevia up 2% USFDA issues Zero observations for Bharuch unit
1719553590 | BIZSTNDRD
BIZSTNDRD
USFDA highlights quality concerns over drugs manufactured in India
1719492517 | BIZSTNDRD
BIZSTNDRD
Indian pharma sites outpace global standards in USFDA inspections for 2023
1719472616 | BIZSTNDRD
BIZSTNDRD
Indian sites fared better in USFDA inspections in recent years, says IPA
1719422346 | BIZSTNDRD
BIZSTNDRD
Alkem Labs shares surge 5% on USFDA's VAI status for Baddi facility
1719305467 | BIZSTNDRD
BIZSTNDRD
Lupin, Eugia recall products from US over manufacturing issues: USFDA
1719124081 | BIZSTNDRD
BIZSTNDRD
USFDA issues warning letter to Sun Pharma's Dadra unit; stock slips 2%
1718861945 | BIZSTNDRD
BIZSTNDRD
Wanbury surges 5% after USFDA issues Zero observations for Patalganga site
1718859169 | BIZSTNDRD
BIZSTNDRD
Alembic gets USFDA nod for generic injection to treat hereditary angioedema
1718612716 | BIZSTNDRD
BIZSTNDRD
USFDA closes inspection of Lupin's facility with zero 483 observations
1718364086 | BIZSTNDRD
BIZSTNDRD
Zydus gets tentative nod from USFDA for blood pressure lowering drug
1718355963 | BIZSTNDRD
BIZSTNDRD
Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit
1718256940 | BIZSTNDRD
BIZSTNDRD
Buzzing stocks, June 10: Order boost for KEC, RVNL; USFDA action on DRL
1717986843 | BIZSTNDRD
BIZSTNDRD
USFDA issues Form 483 with four observations to Dr Reddy's API unit
1717782856 | BIZSTNDRD
BIZSTNDRD
Covid shots should target JN.1, KP.2 subvariants in 2024-25 campaign: USFDA
1717422000 | BIZSTNDRD
BIZSTNDRD
Sun Pharma, Dr Reddy's pull drugs in US over manufacturing issues: USFDA
1717078495 | BIZSTNDRD